Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James H Feusner

Showing results (41-50 of 53) with videos related to

Pageof 6
Sort By:
Pediatric Blood & Cancer|March 2, 2012
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology GroupMatthew A Kutny, Barry K Moser, Kristina Laumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631Matthew A Kutny, Todd A Alonzo, Robert B Gerbing, et al.
Blood|October 24, 2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocolMartin S Tallman, Janet W Andersen, Charles A Schiffer, et al.
Cancer Causes & Control : CCC|August 11, 2012
Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemiaAnand P Chokkalingam, Catherine Metayer, Ghislaine Scelo, et al.
Blood|August 14, 2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710Bayard L Powell, Barry Moser, Wendy Stock, et al.
Leukemia Research|March 27, 2013
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129Dan Douer, Lynette N Zickl, Charles A Schiffer, et al.
JAMA Oncology|November 11, 2021
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 TrialMatthew A Kutny, Todd A Alonzo, Oussama Abla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup studyHoward M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Cancer|April 4, 2003
Fibrolamellar hepatocellular carcinoma in children and adolescentsHoward M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Annals of Hematology|June 10, 2017
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyOussama Abla, Raul C Ribeiro, Anna Maria Testi, et al.
Pageof 6

Showing results (41-50 of 53) with videos related to

Sort By:
Pageof 6
Pediatric Blood & Cancer|March 2, 2012
FLT3 mutation status is a predictor of early death in pediatric acute promyelocytic leukemia: a report from the Children's Oncology GroupMatthew A Kutny, Barry K Moser, Kristina Laumann, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|August 3, 2017
Arsenic Trioxide Consolidation Allows Anthracycline Dose Reduction for Pediatric Patients With Acute Promyelocytic Leukemia: Report From the Children's Oncology Group Phase III Historically Controlled Trial AAML0631Matthew A Kutny, Todd A Alonzo, Robert B Gerbing, et al.
Blood|October 24, 2002
All-trans retinoic acid in acute promyelocytic leukemia: long-term outcome and prognostic factor analysis from the North American Intergroup protocolMartin S Tallman, Janet W Andersen, Charles A Schiffer, et al.
Cancer Causes & Control : CCC|August 11, 2012
Fetal growth and body size genes and risk of childhood acute lymphoblastic leukemiaAnand P Chokkalingam, Catherine Metayer, Ghislaine Scelo, et al.
Blood|August 14, 2010
Arsenic trioxide improves event-free and overall survival for adults with acute promyelocytic leukemia: North American Leukemia Intergroup Study C9710Bayard L Powell, Barry Moser, Wendy Stock, et al.
Leukemia Research|March 27, 2013
All-trans retinoic acid and late relapses in acute promyelocytic leukemia: very long-term follow-up of the North American Intergroup Study I0129Dan Douer, Lynette N Zickl, Charles A Schiffer, et al.
JAMA Oncology|November 11, 2021
Assessment of Arsenic Trioxide and All-trans Retinoic Acid for the Treatment of Pediatric Acute Promyelocytic Leukemia: A Report From the Children's Oncology Group AAML1331 TrialMatthew A Kutny, Todd A Alonzo, Oussama Abla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 18, 2002
Hepatocellular carcinoma in children and adolescents: results from the Pediatric Oncology Group and the Children's Cancer Group intergroup studyHoward M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Cancer|April 4, 2003
Fibrolamellar hepatocellular carcinoma in children and adolescentsHoward M Katzenstein, Mark D Krailo, Marcio H Malogolowkin, et al.
Annals of Hematology|June 10, 2017
Predictors of thrombohemorrhagic early death in children and adolescents with t(15;17)-positive acute promyelocytic leukemia treated with ATRA and chemotherapyOussama Abla, Raul C Ribeiro, Anna Maria Testi, et al.
Pageof 6